Stocks · News reference
DataMEDS AI (NASDAQ:MEDS) reported quarterly losses of $(7.13) per share. This is a 32.04 percent decrease over losses of $(5.40) per share from the same period last year. The company reported $1.780 million in sales
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Gainers Veeva Systems (NYSE:VEEV) shares increased by 8.7% to $266.15 during Wednesday's after-market session. The market value of their outstanding shares is at $40.0 billion. The company's, Q2 earnings came
Filed: 2026-08-18 AccNo: 0001493152-26-038891 Size: 300 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform